NCT07504445 Clinical Study on the Efficacy and Safety of CAR-DC in the Treatment of Advanced Solid Tumors Status RECRUITING Phase EARLY_PHASE1
NCT07482319 A Clinical Study GK01 Injection in Subjects With Advanced Malignant Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1
NCT07460375 A Study to Evaluate Claudin 18.2-Directed ADC LCB02A in Advanced Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07453394 QLS5132 Combination Therapy in Advanced Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07446816 A Clinical Study Evaluating the Preliminary Anti-tumor Efficacy and Safety of Hemay181 Status RECRUITING Phase PHASE1
NCT07439094 A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT07438093 Safety, Tolerability, and Preliminary Efficacy of Peginterferon α-2b in Combination With an Anti-PD-1 Antibody in Patients With Advanced or Metastatic Malignant Solid Tumors Status NOT_YET_RECRUITING Phase NA
NCT07435038 Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07414316 A Single-Arm, Open-Label Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors. Status RECRUITING Phase EARLY_PHASE1
NCT07412665 A Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors. Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT07397338 Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT07387068 Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT07372625 A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation. Status RECRUITING Phase PHASE1
NCT07359066 An Open-label, First-in-Human, Dose-Escalation and Dose-Expansion Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPR1020 in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT07356453 A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors. Status RECRUITING Phase PHASE1